Homepage
Author:
SUZHOU AIBO BIOTECHNOLOGY CO., LTD
Posted Date:
April 20, 2026
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL
SUZHOU AIBO BIOTECHNOLOGY CO., LTD
April 20, 2026